文献速递传染病防控与疫情报告职业卫生

医护人员接触后续实验室确诊猴痘患者的情况——科罗拉多州,2022年

Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Monkeypox Patients - Colorado, 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-09-23

科罗拉多州评估2022年5月1日至7月31日期间医护人员接触后续确诊猴痘患者时的防护与暴露风险。313名医护人员中23%使用了全部推荐个人防护装备,28%为高风险或中风险暴露,其中48%接种了JYNNEOS疫苗。暴露后21天内无医护人员感染猴痘,提示医疗机构内传播风险低。

要点

  • 313名接触后续确诊猴痘患者的医护人员中,23%使用了全部推荐个人防护装备。
  • 28%的暴露医护人员为高风险或中风险暴露,其中48%接种了JYNNEOS疫苗。
  • 暴露后21天内无医护人员感染猴痘。

核心结论

  • 结果表明医疗机构内猴痘传播风险低。
  • 感染预防培训在所有医疗机构中都很重要,这些发现可指导未来个人防护装备建议和风险分级的更新。

研究设计与样本

  • 科罗拉多州公共卫生与环境部评估医护人员在诊疗后续诊断为正痘病毒属感染或猴痘患者期间的暴露和个人防护装备使用情况。
  • 2022年5月1日至7月31日期间,共313名医护人员在佩戴各种组合个人防护装备的情况下接触了后续确诊猴痘感染的患者。

主要发现

  • 23%的暴露医护人员在暴露期间使用了全部推荐的个人防护装备。
  • 28%的暴露医护人员被认为属于高风险或中风险暴露,因而有资格接受JYNNEOS疫苗暴露后预防;其中48%(占全部暴露医护人员的12%)接种了疫苗。
  • 个人防护装备使用因机构类型而异:性传播感染门诊和社区健康中心的医护人员对推荐个人防护装备的依从性最高,初级保健和紧急护理机构的依从性最低。
  • 暴露后21天内无医护人员感染猴痘。

关键数值与推荐

  • CDC目前建议医护人员在诊疗疑似或确诊猴痘患者时佩戴隔离衣、手套、护目装备和N95(或更高级别)呼吸器以保护自身免受感染。

临床怎么用

  • 感染预防培训在所有医疗机构中都很重要,这些发现可指导未来个人防护装备建议和风险分级的更新。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The risk for monkeypox transmission to health care personnel (HCP) caring for symptomatic patients is thought to be low but has not been thoroughly assessed in the context of the current global outbreak (1). Monkeypox typically spreads through close physical (often skin-to-skin) contact with lesions or scabs, body fluids, or respiratory secretions of a person with an active monkeypox infection. CDC currently recommends that HCP wear a gown, gloves, eye protection, and an N95 (or higher-level) respirator while caring for patients with suspected or confirmed monkeypox to protect themselves from infection† (1,2). The Colorado Department of Public Health and Environment (CDPHE) evaluated HCP exposures and personal protective equipment (PPE) use in health care settings during care of patients who subsequently received a diagnosis of Orthopoxvirus infection (presumptive monkeypox determined by a polymerase chain reaction [PCR] DNA assay) or monkeypox (real-time PCR assay and genetic sequencing performed by CDC). During May 1-July 31, 2022, a total of 313 HCP interacted with patients with subsequently diagnosed monkeypox infections while wearing various combinations of PPE; 23% wore all recommended PPE during their exposures. Twenty-eight percent of exposed HCP were considered to have had high- or intermediate-risk exposures and were therefore eligible to receive postexposure prophylaxis (PEP) with the JYNNEOS vaccine§; among those, 48% (12% of all exposed HCP) received the vaccine. PPE use varied by facility type: HCP in sexually transmitted infection (STI) clinics and community health centers reported the highest adherence to recommended PPE use, and primary and urgent care settings reported the lowest adherence. No HCP developed a monkeypox infection during the 21 days after exposure. These results suggest that the risk for transmission of monkeypox in health care settings is low. Infection prevention training is important in all health care settings, and these findings can guide future updates to PPE recommendations and risk classification in health care settings.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Marshall KE, Barton M, Nichols J, et al. Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Monkeypox Patients - Colorado, 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36136939. doi:10.15585/mmwr.mm7138e2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。